Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) given intravenously for short-term management of pain and reduction of post-operative pain by inhibiting prostaglandin synthesis peripherally. It is contraindicated in patients with hypersensitivity, bleeding risks, or active peptic ulcer disease. Common adverse effects include dizziness, headache, nausea, and potential gastrointestinal bleeding. Nurses monitor patients for signs of gastrointestinal distress, bleeding, cardiac issues, and central nervous system effects.
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) given intravenously for short-term management of pain and reduction of post-operative pain by inhibiting prostaglandin synthesis peripherally. It is contraindicated in patients with hypersensitivity, bleeding risks, or active peptic ulcer disease. Common adverse effects include dizziness, headache, nausea, and potential gastrointestinal bleeding. Nurses monitor patients for signs of gastrointestinal distress, bleeding, cardiac issues, and central nervous system effects.
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) given intravenously for short-term management of pain and reduction of post-operative pain by inhibiting prostaglandin synthesis peripherally. It is contraindicated in patients with hypersensitivity, bleeding risks, or active peptic ulcer disease. Common adverse effects include dizziness, headache, nausea, and potential gastrointestinal bleeding. Nurses monitor patients for signs of gastrointestinal distress, bleeding, cardiac issues, and central nervous system effects.
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) given intravenously for short-term management of pain and reduction of post-operative pain by inhibiting prostaglandin synthesis peripherally. It is contraindicated in patients with hypersensitivity, bleeding risks, or active peptic ulcer disease. Common adverse effects include dizziness, headache, nausea, and potential gastrointestinal bleeding. Nurses monitor patients for signs of gastrointestinal distress, bleeding, cardiac issues, and central nervous system effects.
Name and Dose, Frequency, Mechanism of Indication Contraindications Adverse Effect Nursing
Classification of Route, Duration of Action Responsibilities
Drugs Administration Generic Name: Dose: 30 mg It inhibits synthesis Short-term Hypersensitivity to Central Nervous • Monitor urine Ketorolac Frequency: PRN for of prostaglandins management of pain keterolac; System: drowsiness, output in older pain and is a peripherally and reduction of individuals with dizziness, headache. adults and Brand Name: Route: IV acting analgesics. post-operative pain. complete or partial Gastrointestinal: patients with Toradol syndrome of nasal nausea, dyspepsia, history of polyps, angioedema, GI pain, cardiac Classifications: and bronchospastic hemorrhage. decompensation Central Nervous reaction to aspirin or Other: edema, . System; NSAID, other NSAID’s; sweating, pain at • Monitor signs Analgesic; patient with risk of injection site. and symptoms Antipyretic bleeding; active of GI distress or peptic ulcer disease; bleeding pre- or intra- including operatively. nausea, GI pain, diarrhea, and melena. • Watch for signs and symptoms of GI ulceration and bleeding (bloody emesis, black tarry stools). • Note for possible CNS adverse effects (dizziness and drowsiness). • Do not use other NSAIDs drugs while taking this drug.